Takezako, Naoki
Shibayama, Hirohiko
Handa, Hiroshi
Hagiwara, Shotaro
Ozaki, Shuji
Suzuki, Kenshi
Kosugi, Hiroshi
Ri, Masaki
Sugiura, Isamu
Choi, Ilseung
Miyamoto, Toshihiro
Iida, Shinsuke
Funding for this research was provided by:
Ono Pharmaceutical
Article History
Received: 29 June 2020
Revised: 26 August 2020
Accepted: 24 September 2020
First Online: 10 October 2020
Compliance with ethical standards
:
: Dr. N. Takezako, Dr. H. Handa, Dr. S. Ozaki, Dr. Ilseung Choi, Dr. T Miyamoto, and Dr. S. Hagiwara report grants and personal fees from Ono Pharmaceutical during the conduct of the study. Dr. T Miyamoto reports lecture fees from Bristol-Myers Squibb, Otsuka Pharmaceutical, MSD, Astellas Pharmaceutical, Astellas Amgen Pharmaceutical, Celgene, Abbvie Pharmaceutical, and Takeda Pharmaceutical. Dr. H. Shibayama reports grants and personal fees from Ono Pharmaceutical during the conduct of the study; grants from Astellas, Teijin, Shionogi, Taiho, Merck Sharp & Dohme, and Sumitomo Dainippon; grants and personal fees from Eisai, Celgene, Takeda, Nippon Shinyaku, and Daiichi Sankyo; and personal fees from Novartis, Janssen, Chugai, Kyowa Kirin, Otsuka, Bristol-Myers Squibb, Pfizer, Fujimoto Pharmaceutical, AbbVie, and AstraZeneca outside the submitted work. Dr. K. Suzuki reports grants and personal fees from Ono Pharmaceutical during the conduct of the study; grants and personal fees from Bristol-Myers Squibb, Celgene, and Amgen; and personal fees from Janssen, Takeda, Novartis, Sanofi, and AbbVie outside the submitted work. Dr. H. Kosugi reports grants and personal fees from Ono during the conduct of the study; and personal fees from Chugai, Celgene, Novartis, Bioverative Japan, Merck Sharp & Dohme, Takeda, Janssen, Japan Blood Products Organization, Bristol-Myers Squibb, and Ono Pharmaceutical outside the submitted work. Dr. M. Ri reports grants and personal fees from Ono Pharmaceutical during the conduct of the study; grants and personal fees from Celgene, Janssen, Takeda, Ono Pharmaceutical, Bristol-Myers Squibb, and Sanofi; and grants from Kyowa Kirin outside the submitted work. Dr. I. Sugiura reports no conflict of interest. Dr. S. Iida reports grants and personal fees from Ono Pharmaceutical during the conduct of the study; grants and personal fees from Takeda, Celgene, Janssen, Bristol-Myers Squibb, Daiichi Sankyo, Sanofi, and AbbVie; and grants from Merck Sharp & Dohme, Gilead, and GlaxoSmithKline outside the submitted work.
Free to read: This content has been made available to all.